|
7TZG
Structure of human LAG3 in complex with antibody single-chain variable fragment
Deposited 2022-02-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
23–430(408 aa)
Fragment:ectodomain
Chain D
23–430(408 aa)
Fragment:ectodomain
|
Mutation:M171I
Mutation:M171I
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;1% Tacsimate at pH 5.0, 0.05 M sodium citrate tribasic dihydrate, pH 5.6 and 7% PEG3350
|
Resolution 3.71 Å
R-free 0.275
|
|
7TZH
Structure of human LAG3 domains 3-4 in complex with antibody single chain-variable fragment
Deposited 2022-02-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
261–450(190 aa)
Fragment:ectodomain
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;293.15 K;0.1 M HEPES pH 7.1, 13% PEG20000
|
Resolution 2.43 Å
R-free 0.255
|
|
7TZH
Structure of human LAG3 domains 3-4 in complex with antibody single chain-variable fragment
Deposited 2022-02-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
261–450(190 aa)
Fragment:ectodomain
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;293.15 K;0.1 M HEPES pH 7.1, 13% PEG20000
|
Resolution 2.43 Å
R-free 0.255
|
|
7UM3
Crystal structure of a Fab in complex with a peptide derived from the LAG-3 D1 domain loop insertion
Deposited 2022-04-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
82–97(16 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;298 K;0.1 M Bis-Tris, pH 5.5, 25% PEG3350
|
Resolution 2.40 Å
R-free 0.265
|
|
7UM3
Crystal structure of a Fab in complex with a peptide derived from the LAG-3 D1 domain loop insertion
Deposited 2022-04-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
82–97(16 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;298 K;0.1 M Bis-Tris, pH 5.5, 25% PEG3350
|
Resolution 2.40 Å
R-free 0.265
|
|
8SR0
CryoEM structure of a therapeutic antibody (favezelimab) bound to human LAG3 local refined
Deposited 2023-05-05
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain D
1–525(525 aa)
Chain X
1–525(525 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.53 Å
|
|
9BF9
Human LAG-3-HLA-DR1 complex
Deposited 2024-04-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 8
PDB declaration: tetrameric
|
Chain D
23–429(407 aa)
|
Not recorded
|
SO4 SULFATE ION × 6
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
PEG DI(HYDROXYETHYL)ETHER × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277.15 K;22% PEG 8000, 0.16M Li2SO4, 0.1M HEPES pH 7.6
|
Resolution 3.40 Å
R-free 0.253
|